Clinical Study

Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer

Table 1

Demographics and clinical data.

Morphine aloneMorphine + ropivacaine

Age (years)64.0 ± 13.462.6 ± 9.92
Sex (male/female)11/814/3
Cancer type ()
 Bladder21
 Bile duct10
 Colon21
 Duodenum11
 Esophagus12
 Kidney01
 Liver12
 Lung34
 Pancreas10
 Penis10
 Sarcoma10
 Stomach23
 Ureter21
 Uterus11
Location of pain ()
 Chest23
 Abdomen76
Lower limb
Preoperative systemic opioid type ()
108
 Morphine42
 Oxycodone1011
 Fentanyl54

Data from 36 patients.